An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patientsBritish Journal of Haematology
Volume 156, Issue 4, February 2012, Pages: 481–489, Agostino Cortelezzi, Giuseppe Gritti, Luca Laurenti, Antonio Cuneo, Stefania Ciolli, Nicola Di Renzo, Pellegrino Musto, Francesca R. Mauro, Nicola Cascavilla, Lorenzo Falchi, Francesco Zallio, Vincenzo Callea, Francesco Maura, Sara Martinelli, Alfonso Piciocchi, Gianluigi Reda and Robin Foà, on behalf of the GIMEMA Chronic Lymphoproliferative Disorders Working Party
Article first published online : 9 DEC 2011, DOI: 10.1111/j.1365-2141.2011.08965.x